Kiniksa Pharmaceuticals L...
(KNSA)
undefined
undefined%
At close: undefined
20.20
-0.30%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 107.95M | 122.72M | 122.47M | 114.04M | 46.93M | 307.30M | 45.55M | 55.97M |
Short-Term Investments | 98.42M | 67.89M | 59.73M | 209.44M | 186.45M | 235.33M | - | - |
Long-Term Investments | - | - | - | - | 210.00K | 210.00K | - | - |
Other Long-Term Assets | 827.00K | 5.82M | 8.72M | 5.59M | 210.00K | 643.00K | 25.00K | 8.00K |
Receivables | 21.27M | 20.32M | 3.98M | - | - | - | - | - |
Inventory | 31.12M | 21.60M | 3.67M | - | - | - | - | - |
Other Current Assets | 17.54M | 10.54M | 13.17M | 9.77M | 16.49M | 12.89M | 1.55M | 364.00K |
Total Current Assets | 276.30M | 243.06M | 196.45M | 333.25M | 241.63M | 313.75M | 47.10M | 56.33M |
Property-Plant & Equipment | 12.66M | 7.04M | 8.38M | 10.62M | 8.32M | 6.36M | 125.00K | 84.00K |
Goodwill & Intangibles | 17.25M | 18.25M | 19.25M | - | -210.00K | -210.00K | - | - |
Total Long-Term Assets | 250.03M | 216.61M | 36.35M | 16.21M | 12.91M | 8.21M | 388.00K | 133.00K |
Total Assets | 526.32M | 459.67M | 232.80M | 349.46M | 254.53M | 321.96M | 47.49M | 56.47M |
Account Payables | 8.25M | 7.90M | 1.87M | 503.00K | 5.69M | 10.92M | 1.22M | 212.00K |
Deferred Revenue | 307.00K | 12.00M | 38.03M | 29.20M | 20.41M | - | - | - |
Short-Term Debt | 4.51M | 6.60M | 6.76M | 4.21M | 3.39M | - | - | - |
Other Current Liabilities | 50.61M | 32.56M | 36.19M | 27.13M | 18.74M | 31.64M | 16.21M | 2.09M |
Total Current Liabilities | 63.67M | 47.07M | 44.82M | 31.85M | 27.83M | 42.55M | 17.43M | 2.30M |
Long-Term Debt | 10.01M | 2.62M | 2.67M | 4.88M | 955.00K | - | - | - |
Other Long-Term Liabilities | 1.86M | 1.84M | 270.00K | 805.00K | 326.00K | 144.00K | 119.77M | 79.90M |
Total Long-Term Liabilities | 23.82M | 16.46M | 2.94M | 5.68M | 1.28M | 144.00K | 119.77M | 79.90M |
Total Liabilities | 87.48M | 63.52M | 47.76M | 37.53M | 29.11M | 42.70M | 137.20M | 82.20M |
Total Debt | 12.26M | 5.92M | 6.05M | 6.99M | 2.65M | - | - | - |
Common Stock | 20.00K | 19.00K | 18.00K | 18.00K | 15.00K | 13.00K | 1K | 1K |
Retained Earnings | -477.95M | -492.03M | -675.40M | -517.47M | -356.09M | -194.22M | -91.00M | -26.13M |
Comprehensive Income | 6.00K | 44.00K | -66.00K | -34.00K | 33.00K | -4.00K | -52.00K | -24.00K |
Shareholders Equity | 438.84M | -492.03M | -675.40M | -517.47M | -356.09M | -194.22M | -89.71M | -25.73M |
Total Investments | 98.42M | 67.89M | 59.73M | 209.44M | 186.45M | 235.33M | - | - |